Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2022
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiologyAurore Delvenne, Johan Gobom, Betty Tijms, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Molecular Psychiatry|February 17, 2022
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammationAlexander Neumann, Fahri Küçükali, Isabelle Bos, et al.
Alzheimer'S Research & Therapy|September 29, 2018
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyMara Ten Kate, Alberto Redolfi, Enrico Peira, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 5, 2022
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traitsFahri Küçükali, Alexander Neumann, Jasper Van Dongen, et al.
Frontiers in Aging Neuroscience|April 7, 2022
Genome-Wide Association Study of Alzheimer's Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery DatasetJan Homann, Tim Osburg, Olena Ohlei, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 4, 2019
Inflammatory biomarkers in Alzheimer's disease plasmaAngharad R Morgan, Samuel Touchard, Claire Leckey, et al.
The Lancet. Neurology|September 19, 2019
Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling studyIngrid S van Maurik, Stephanie J Vos, Isabelle Bos, et al.
Pageof 6